Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
18
-
Total 13F shares, excl. options
-
561K
-
Shares change
-
-18.7K
-
Total reported value, excl. options
-
$15.5M
-
Value change
-
-$870K
-
Number of buys
-
7
-
Number of sells
-
-9
-
Price
-
$27.56
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q3 2025
22 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q3 2025.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 18 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 561K shares
of 57.1M outstanding shares and own 0.98% of the company stock.
Largest 10 shareholders include Pacer Advisors, Inc. (363K shares), EXCHANGE TRADED CONCEPTS, LLC (65K shares), Voya Investment Management LLC (52.2K shares), Paradiem, LLC (26.3K shares), ARS Investment Partners, LLC (21.5K shares), YOUSIF CAPITAL MANAGEMENT, LLC (12.4K shares), City Center Advisors, LLC (8.01K shares), CWM, LLC (7.5K shares), Avanza Fonder AB (2.92K shares), and GAMMA Investing LLC (1.45K shares).
This table shows the top 18 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.